Home › T-Cell Lymphoma › Florida
T-Cell Lymphoma clinical trials in Florida
8 studies for T-Cell Lymphoma are looking for participants at sites in Florida.
Cities in Florida
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
- Sylvester Comprehensive Cancer Center University of Miami Miller School of Medicine, Miami
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06561048Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy
- Mayo Clinic in Florida, Jacksonville
- Moffitt Cancer Center-International Plaza, Tampa
- Moffitt Cancer Center - McKinley Campus, Tampa
- and 1 more
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 14, 2026 · NCT06724237Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
- UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT04803201CD4CAR for CD4+ Leukemia and Lymphoma
- University of Miami Sylvester Comprehensive Cancer Center, Miami
RecruitingPhase 1
Ages 12 and older · All sexes · Updated Jun 24, 2026 · NCT03829540A Phase 1/2 Study of STP938 (Dencatistat) for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas
- Florida Cancer Specialists, Sarasota
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jun 16, 2026 · NCT05463263A Registry for People With T-cell Lymphoma
- University of Miami (Data Collection Only), Miami
- Moffitt Cancer Center (Data Collection Only), Tampa
RecruitingObservational study
All ages · All sexes · Updated May 20, 2026 · NCT05978141MB-105 in Patients With CD5 Positive T-cell Lymphoma
- Moffitt Cancer Center Magnolia Campus, Tampa
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 3, 2025 · NCT06534060Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- University of Miami, Miami
RecruitingPhase 1
Ages 1 to 21 · All sexes · Updated Dec 6, 2024 · NCT05476770From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.